Kinex Says the FDA Has Approved its IND for Oraxol

The FDA has accepted Kinex’s IND for Oraxol for oral delivery of paclitaxel. This is the second Kinex IND the agency has approved this year and the company expects to proceed with Phase I/Ib clinical trials.
Yahoo! Finance